Related Experiment Video

Updated: Jun 6, 2026

Label-Free Immunoprecipitation Mass Spectrometry Workflow for Large-scale Nuclear Interactome Profiling
11:19

Label-Free Immunoprecipitation Mass Spectrometry Workflow for Large-scale Nuclear Interactome Profiling

Published on: November 17, 2019

Activation, regulation, and inhibition of DYRK1A

Walter Becker1, Wolfgang Sippl

  • 1Institute of Pharmacology and Toxicology, Medical Faculty of the RWTH Aachen University, Aachen, Germany. wbecker@ukaachen.de

The FEBS Journal
|December 4, 2010
PubMed

Insights

Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is crucial for brain development and linked to neurodegenerative diseases. Its activity is not regulated by tyrosine phosphorylation but by gene expression, protein interactions, and nuclear translocation.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) plays a vital role in neuronal development and brain function.
  • Elevated DYRK1A levels are implicated in neurodegenerative diseases and Down syndrome-associated intellectual disability.

Purpose of the Study:

  • To review the molecular mechanisms regulating DYRK1A activity.
  • To explore the role of tyrosine autophosphorylation and other regulatory controls.
  • To evaluate DYRK1A inhibitors for therapeutic potential.

Main Methods:

  • Literature review of DYRK1A regulation.
  • Analysis of tyrosine autophosphorylation in kinase activation.
  • Comparison of small molecule inhibitors targeting DYRK1A.

Main Results:

  • DYRK1A self-activation via tyrosine autophosphorylation is an ancestral kinase feature.
  • Tyrosine phosphorylation does not directly regulate DYRK1A enzymatic activity.
  • Gene expression, protein interactions, and nuclear translocation are key regulatory mechanisms.
  • Harmine is a potent and selective DYRK1A inhibitor with utility in cellular assays.

Conclusions:

  • DYRK1A regulation is complex, involving pre- and post-translational modifications.
  • Understanding DYRK1A control is critical for addressing associated neurobiological disorders.
  • Selective inhibitors like harmine offer promising avenues for research and potential therapeutic interventions.

More Related Videos

Optogenetic Inhibition of Rho1-Mediated Actomyosin Contractility Coupled with Measurement of Epithelial Tension in Drosophila Embryos12:35

Optogenetic Inhibition of Rho1-Mediated Actomyosin Contractility Coupled with Measurement of Epithelial Tension in Drosophila Embryos

Published on: April 14, 2023

Assaying Protein Kinase Activity with Radiolabeled ATP08:05

Assaying Protein Kinase Activity with Radiolabeled ATP

Published on: May 26, 2017

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...